80 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
and terms and conditions included in the contracts with the service providers. In addition, in certain circumstances, the determination of the nature … . The Company may invest its excess cash in mutual funds that are classified based on the nature of their underlying securities and their availability for use
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
current and future preclinical and clinical development projects. Due to the inherently unpredictable nature of preclinical and clinical development … is, by its nature, uncertain given that estimates depend on events over which we may not have control. If market and other conditions change from those
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
that are classified based on the nature of their underlying securities and their availability for use in current operations. The Company’s marketable
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
in accordance with the volume and nature of their services.
FOR
AGAINST
ABSTAIN
The undersigned hereby acknowledges receipt of the Notice of the Annual
6-K
EX-99.1
53a6yg1jdoj
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.1
xaob5eezp0r
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
dg82m1dv 8v6kp
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
ob7wo 492u
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
y7e6q7vzvjc0ntkj0t0
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
vwny1be7ml6u ub
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
4r9r37 sq62g2p
30 Dec 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-99.1
xoqrx6w66cs88cr3yi46
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
yl9ipjkxz9m3ug cg
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
ix4fyjyp
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.2
0f3old a453wrbmy3nb
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
c6uv1gaqvf iz29o
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
ivc lfo3lqjpp37
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.2
9ktjzokn9ln1ol5g7
27 May 22
Condensed Consolidated Financial Statements
4:39pm